Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Social distress among Medical Oncologists and other Health Care Professionals during the first wave of COVID-19 pandemic in Italy

(2021) R. Berardi et al.   ESMO Open

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Assessing the impact of COVID‐19 on registered interventional clinical trials

(2021) Nour Hawila et al.   CTS-Clinical and Translational Science

Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy

(2021) Luca Cantini et al.   Journal of Clinical Medicine

Patient prioritization and management during the COVID-19 pandemic

(2021) Mohamed Aggour et al.   INTERVENTIONAL NEURORADIOLOGY

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

(2020) Masumi Ueda et al.   Journal of the National Comprehensive Cancer Network

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

(2020) Avinash G Dinmohamed et al.   LANCET ONCOLOGY

Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care

(2020) Daniel Jones et al.   LANCET ONCOLOGY

Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus

(2020) G. Curigliano et al.   ANNALS OF ONCOLOGY

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

(2020) Elizabeth Lerner Papautsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?

(2020) Moran Amit et al.   EUROPEAN JOURNAL OF CANCER

Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19

(2020) Charles W. Helsper et al.   EUROPEAN JOURNAL OF CANCER CARE

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

(2020) Marina Chiara Garassino et al.   LANCET ONCOLOGY

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

(2020) Amit Sud et al.   LANCET ONCOLOGY

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

(2020) Camille Maringe et al.   LANCET ONCOLOGY

COVID-19 and cancer

(2020) Norman E. Sharpless   SCIENCE

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

(2020) Harvey W. Kaufman et al.   JAMA Network Open

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers

(2020) Eugene B. Cone et al.   JAMA Network Open